Beta-hc
Drug - Beta-hc
The trade name of the product as shown on the labeling.
Dosage -
LOTION; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Hydrocortisone
Multiple ingredients are in alphabetical order.
Strength -
1%
The potency of the active ingredient(s), Hydrocortisone. May repeat for multiple part products.
Applicant -
BETA DERMAC
The firm name holding legal responsibility for Beta-hc. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
089495
The FDA assigned number to Beta-hc. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Beta-hc. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jan 25, 1988
The date Beta-hc was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Beta-hc. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Beta-hc is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Beta Dermaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Beta-hc.
Beta-hc
|